{"id":"https://openalex.org/W3083349647","doi":"https://doi.org/10.1158/1078-0432.ccr-20-0452","title":"Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors","display_name":"Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors","publication_year":2020,"publication_date":"2020-09-04","ids":{"openalex":"https://openalex.org/W3083349647","doi":"https://doi.org/10.1158/1078-0432.ccr-20-0452","mag":"3083349647","pmid":"https://pubmed.ncbi.nlm.nih.gov/32887725"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-20-0452","doi":"https://doi.org/10.1158/1078-0432.ccr-20-0452","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-0452","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/26/23/6196/2064383/6196.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/26/23/6196/2064383/6196.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052730435","display_name":"Ani Sarkis Balmanoukian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104507","display_name":"Angeles Clinic and Research Institute","ror":"https://ror.org/01ct2ab72","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834","https://openalex.org/I4210104507"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ani S. Balmanoukian","raw_affiliation_strings":["1The Angeles Clinic and Research Institute, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Angeles Clinic and Research Institute, Los Angeles, California","institution_ids":["https://openalex.org/I4210104507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103514741","display_name":"Jeffrey R. Infante","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey R. Infante","raw_affiliation_strings":["2Janssen Inc, Spring House, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Janssen Inc, Spring House, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110806811","display_name":"Raid M. Aljumaily","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raid Aljumaily","raw_affiliation_strings":["3University of Oklahoma, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Oklahoma, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005436649","display_name":"Aung Naing","orcid":"https://orcid.org/0000-0002-4803-8513","observed_orcids":["https://orcid.org/0000-0002-4803-8513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aung Naing","raw_affiliation_strings":["4MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-4803-8513","affiliations":[{"raw_affiliation_string":"4MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076663691","display_name":"Ashish Vittalrao Chintakuntlawar","orcid":"https://orcid.org/0000-0002-2907-6522","observed_orcids":["https://orcid.org/0000-0002-2907-6522"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish V. Chintakuntlawar","raw_affiliation_strings":["5Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075877134","display_name":"Naiyer A. Rizvi","orcid":"https://orcid.org/0000-0002-1134-7494","observed_orcids":["https://orcid.org/0000-0002-1134-7494"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naiyer A. Rizvi","raw_affiliation_strings":["6Columbia University Medical Center, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-1134-7494","affiliations":[{"raw_affiliation_string":"6Columbia University Medical Center, New York, New York","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002341560","display_name":"Helen J. Ross","orcid":"https://orcid.org/0000-0003-4280-3066","observed_orcids":["https://orcid.org/0000-0003-4280-3066"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen J. Ross","raw_affiliation_strings":["7Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069690249","display_name":"Michael S. Gordon","orcid":"https://orcid.org/0000-0002-7679-9504","observed_orcids":["https://orcid.org/0000-0002-7679-9504"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Gordon","raw_affiliation_strings":["8HonorHealth Research Institute, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8HonorHealth Research Institute, Scottsdale, Arizona","institution_ids":["https://openalex.org/I4210130412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113860440","display_name":"Philip R. Mallinder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Philip R. Mallinder","raw_affiliation_strings":["9AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071576053","display_name":"Nairouz Elgeioushi","orcid":"https://orcid.org/0009-0009-5303-9535","observed_orcids":["https://orcid.org/0009-0009-5303-9535"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nairouz Elgeioushi","raw_affiliation_strings":["10AstraZeneca, Gaithersburg, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10AstraZeneca, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ignacio Gonz\u00e1lez-Garc\u00eda","orcid":"https://orcid.org/0000-0003-3663-3259","observed_orcids":["https://orcid.org/0000-0003-3663-3259"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ignacio Gonz\u00e1lez-Garc\u00eda","raw_affiliation_strings":["9AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-3663-3259","affiliations":[{"raw_affiliation_string":"9AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080517610","display_name":"Nathan E. Standifer","orcid":"https://orcid.org/0000-0002-9328-1889","observed_orcids":["https://orcid.org/0000-0002-9328-1889"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan Standifer","raw_affiliation_strings":["11AstraZeneca, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11AstraZeneca, South San Francisco, California","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066935220","display_name":"Jennifer A. Cann","orcid":"https://orcid.org/0000-0002-7341-0620","observed_orcids":["https://orcid.org/0000-0002-7341-0620"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Cann","raw_affiliation_strings":["10AstraZeneca, Gaithersburg, Maryland"],"raw_orcid":"https://orcid.org/0000-0002-7341-0620","affiliations":[{"raw_affiliation_string":"10AstraZeneca, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001220282","display_name":"Nicholas M. Durham","orcid":"https://orcid.org/0000-0003-1065-8474","observed_orcids":["https://orcid.org/0000-0003-1065-8474"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Durham","raw_affiliation_strings":["10AstraZeneca, Gaithersburg, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10AstraZeneca, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017209300","display_name":"Shahram Rahimian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahram Rahimian","raw_affiliation_strings":["10AstraZeneca, Gaithersburg, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10AstraZeneca, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088647694","display_name":"Rakesh Kumar","orcid":"https://orcid.org/0000-0002-4627-3667","observed_orcids":["https://orcid.org/0000-0002-4627-3667"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rakesh Kumar","raw_affiliation_strings":["10AstraZeneca, Gaithersburg, Maryland"],"raw_orcid":"https://orcid.org/0000-0002-4627-3667","affiliations":[{"raw_affiliation_string":"10AstraZeneca, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005375804","display_name":"Crystal Shereen Denlinger","orcid":"https://orcid.org/0000-0002-5663-7751","observed_orcids":["https://orcid.org/0000-0002-5663-7751"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal S. Denlinger","raw_affiliation_strings":["12Fox Chase Cancer Center, Philadelphia, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0002-5663-7751","affiliations":[{"raw_affiliation_string":"12Fox Chase Cancer Center, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5052730435"],"corresponding_institution_ids":["https://openalex.org/I4210104507"],"apc_list":null,"apc_paid":null,"fwci":3.3583,"has_fulltext":true,"cited_by_count":55,"citation_normalized_percentile":{"value":0.94455629,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"26","issue":"23","first_page":"6196","last_page":"6203"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9070000052452087},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9480000138282776},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cd4-effector-memory-t-cells","display_name":"CD4+ effector memory T cells","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cytokine-response","display_name":"cytokine response","score":0.5550000071525574},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6850000023841858},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8440812826156616},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7531240582466125},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6850993633270264},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6766511797904968},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.609379768371582},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6066281795501709},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5444452166557312},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5181880593299866},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.48328307271003723},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4624076187610626},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37869131565093994},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23079019784927368},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2046116590499878}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053450","descriptor_name":"Glucocorticoid-Induced TNFR-Related Protein","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D053450","descriptor_name":"Glucocorticoid-Induced TNFR-Related Protein","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D053450","descriptor_name":"Glucocorticoid-Induced TNFR-Related Protein","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-20-0452","doi":"https://doi.org/10.1158/1078-0432.ccr-20-0452","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-0452","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/26/23/6196/2064383/6196.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:32887725","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32887725","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-20-0452","doi":"https://doi.org/10.1158/1078-0432.ccr-20-0452","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-0452","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/26/23/6196/2064383/6196.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3083349647.pdf","grobid_xml":"https://content.openalex.org/works/W3083349647.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1985735048","https://openalex.org/W1986697585","https://openalex.org/W2004409905","https://openalex.org/W2104072610","https://openalex.org/W2106728539","https://openalex.org/W2134435470","https://openalex.org/W2137704240","https://openalex.org/W2145066420","https://openalex.org/W2234091475","https://openalex.org/W2509587195","https://openalex.org/W2560229181","https://openalex.org/W2583347850","https://openalex.org/W2619904489","https://openalex.org/W2626962960","https://openalex.org/W2691659998","https://openalex.org/W2738837305","https://openalex.org/W2810896552","https://openalex.org/W2891368406","https://openalex.org/W2894508341","https://openalex.org/W2947685712","https://openalex.org/W2988709916","https://openalex.org/W6754925677","https://openalex.org/W6763016613","https://openalex.org/W6910975246"],"related_works":["https://openalex.org/W2898306504","https://openalex.org/W2889929834","https://openalex.org/W2583347850","https://openalex.org/W2740542282","https://openalex.org/W2480562271","https://openalex.org/W4412653705","https://openalex.org/W2691659998","https://openalex.org/W2894508341","https://openalex.org/W2805870641","https://openalex.org/W2145335139"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"The":[2,191],"safety":[3,81,218],"and":[4,40,47,66,82,87,96,117,121,136,156,230],"preliminary":[5],"efficacy":[6],"of":[7,243,245],"MEDI1873,":[8],"an":[9,23],"agonistic":[10],"IgG1":[11],"fusion":[12],"protein":[13,18],"targeting":[14],"glucocorticoid-induced":[15],"TNF":[16],"receptor\u2013related":[17],"(GITR),":[19],"were":[20,51,80,150],"evaluated":[21],"in":[22,31,57,198,233],"open-label,":[24],"first-in-human,":[25],"phase":[26],"I,":[27],"dose":[28,55,163,187],"escalation":[29,56],"study":[30],"previously":[32],"treated":[33],"patients":[34,100,200,208],"with":[35,182,227],"advanced":[36],"solid":[37],"tumors.":[38],"Patients":[39],"Methods:":[41],"Two":[42],"single-patient":[43],"cohorts":[44,59],"at":[45,60,186],"1.5":[46],"3":[48,107,114,123],"mg":[49,222],"i.v.":[50,223],"followed":[52],"by":[53],"3+3":[54],"six":[58],"7.5,":[61],"25,":[62],"75,":[63],"250,":[64],"500,":[65],"750":[67],"mg,":[68],"all":[69],"every":[70,224],"2":[71,225],"weeks,":[72],"for":[73],"up":[74,141,219],"to":[75,142,220],"52":[76],"weeks.":[77,213],"Primary":[78],"endpoints":[79,90],"tolerability,":[83],"dose-limiting":[84],"toxicities":[85],"(DLT),":[86],"MTD.":[88],"Secondary":[89],"included":[91],"antitumor":[92],"activity,":[93,229],"pharmacokinetics,":[94],"immunogenicity,":[95],"pharmacodynamics.":[97],"Results:":[98],"Forty":[99],"received":[101],"MEDI1873.":[102],"Three":[103],"experienced":[104],"DLTs:":[105],"grade":[106,113,122],"worsening":[108],"tumor":[109,247],"pain":[110],"(250":[111],"mg);":[112,120],"nausea,":[115],"vomiting,":[116],"headache":[118,151],"(500":[119],"non-ST":[124],"segment":[125],"elevation":[126],"myocardial":[127],"infarction":[128],"(750":[129],"mg).":[130],"An":[131],"MTD":[132],"was":[133,138,162,167,194],"not":[134,240],"reached":[135],"treatment":[137],"well":[139,178],"tolerated":[140],"500":[143,221],"mg.":[144,190],"Most":[145],"common":[146],"treatment-related":[147],"adverse":[148],"events":[149],"(25%),":[152],"infusion-related":[153],"reaction":[154],"(17.5%),":[155],"decreased":[157],"appetite":[158],"(17.5%).":[159],"MEDI1873":[160,169,215],"exposure":[161],"proportional.":[164],"Antidrug\u2013antibody":[165],"incidence":[166],"low.":[168],"increased":[170],"peripheral":[171],"CD4+":[172],"effector":[173,183],"memory":[174],"T-cell":[175,184],"proliferation":[176],"as":[177,179],"cytokines":[180],"associated":[181],"activation":[185],"levels":[188],"\u226575":[189],"best":[192],"response":[193],"stable":[195],"disease":[196],"(SD)":[197],"17":[199],"(42.5%),":[201],"including":[202],"1":[203],"unconfirmed":[204],"partial":[205],"response.":[206,248],"Eight":[207],"(20.0%)":[209],"had":[210],"SD":[211,232],"\u226524":[212],"Conclusions:":[214],"showed":[216],"acceptable":[217],"weeks":[226],"pharmacodynamics":[228],"prolonged":[231],"some":[234],"patients.":[235],"However,":[236],"further":[237],"development":[238],"is":[239],"planned":[241],"because":[242],"lack":[244],"demonstrated":[246]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":8}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-09-11T00:00:00"}